Cristiane Von Werne Baes1, Sandra M de Carvalho Tofoli1, Camila Maria S Martins1, Mario F Juruena2. 1. Department of Neuroscience and Behaviour, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brasil. 2. Stress and Affective Disorders Programme, Department of Neurosciences and Behaviour, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brasil.
Abstract
OBJECTIVE: The mechanisms involved in the dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, especially in the functioning of glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) in depressed patients, are not well elucidated. The objective of this study was to conduct a systematic review of articles that assess the HPA axis activity from GR and MR in depressed patients and healthy controls with or without early life stress. METHODS: We conducted a systematic review of articles in PubMed, SCOPUS and SciELO published between 2000 and 2011, using the following search terms: child abuse, depression, HPA axis, dexamethasone, prednisolone, fludrocortisone and spironolactone. Thirty-four papers were selected for this review. RESULTS: Most studies identified in this review used the dexamethasone/corticotropin-releasing hormone test and dexamethasone suppression test. In these studies, hypercortisolaemia was associated with depression. We identified three studies with the Prednisolone suppression test, only one study with the use of fludrocortisone and one with spironolactone. This review found nine studies that evaluated the HPA axis in individuals with early life stress. CONCLUSIONS: The majority of the studies assessed in this review show that early life stress leads to permanent changes in the HPA axis and may lead to development of depression in adults. The most consistent findings in the literature show increased activity of the HPA axis in depression associated with hypercortisolaemia and reduced inhibitory feedback. These findings suggest that this dysregulation of the HPA axis is partially attributable to an imbalance between GR and MR. Evidences have consistently showed that GR function is impaired in major depression, but few studies have assessed the activity of MR in depression and early life stress.
OBJECTIVE: The mechanisms involved in the dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, especially in the functioning of glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) in depressedpatients, are not well elucidated. The objective of this study was to conduct a systematic review of articles that assess the HPA axis activity from GR and MR in depressedpatients and healthy controls with or without early life stress. METHODS: We conducted a systematic review of articles in PubMed, SCOPUS and SciELO published between 2000 and 2011, using the following search terms: child abuse, depression, HPA axis, dexamethasone, prednisolone, fludrocortisone and spironolactone. Thirty-four papers were selected for this review. RESULTS: Most studies identified in this review used the dexamethasone/corticotropin-releasing hormone test and dexamethasone suppression test. In these studies, hypercortisolaemia was associated with depression. We identified three studies with the Prednisolone suppression test, only one study with the use of fludrocortisone and one with spironolactone. This review found nine studies that evaluated the HPA axis in individuals with early life stress. CONCLUSIONS: The majority of the studies assessed in this review show that early life stress leads to permanent changes in the HPA axis and may lead to development of depression in adults. The most consistent findings in the literature show increased activity of the HPA axis in depression associated with hypercortisolaemia and reduced inhibitory feedback. These findings suggest that this dysregulation of the HPA axis is partially attributable to an imbalance between GR and MR. Evidences have consistently showed that GR function is impaired in major depression, but few studies have assessed the activity of MR in depression and early life stress.
Authors: Jan Terock; Sandra Van der Auwera; Deborah Janowitz; Katharina Wittfeld; Alexander Teumer; Hans J Grabe Journal: Mol Genet Genomic Med Date: 2020-06-18 Impact factor: 2.183
Authors: Nayara Cobra Barreiro Barroca; Cristiane Von Werne Baes; Camila Maria Severi Martins-Monteverde; Nayanne Beckmann Bosaipo; Marcia Santos da Silva Umeoka; Julian Tejada; José Antunes-Rodrigues; Margaret de Castro; Mario Francisco Juruena; Norberto Garcia-Cairasco; Eduardo Henrique de Lima Umeoka Journal: eNeuro Date: 2021-01-15
Authors: Maria Dobielska; Natalia Karina Bartosik; Kamil A Zyzik; Edward Kowalczyk; Michał Seweryn Karbownik Journal: Front Psychiatry Date: 2022-06-09 Impact factor: 5.435
Authors: Kate Ryan Kuhlman; James L Abelson; Stefanie E Mayer; Nirmala Rajaram; Hedieh Briggs; Elizabeth Young Journal: Stress Date: 2021-06-01 Impact factor: 3.493
Authors: Nichola M Brydges; Rowen Jin; Jonathan Seckl; Megan C Holmes; Amanda J Drake; Jeremy Hall Journal: Brain Behav Date: 2013-10-30 Impact factor: 2.708
Authors: I M Steine; T Zayats; C Stansberg; S Pallesen; J Mrdalj; B Håvik; J Soulé; J Haavik; A M Milde; S Skrede; R Murison; J Krystal; J Grønli Journal: Transl Psychiatry Date: 2016-12-13 Impact factor: 6.222